Rectal Cancer Disappears After Experimental Use of Immunotherapy
Posted:
12 patients with rectal cancer treated with dostarlimab - an anti PD1 monoclonal antibody with complete response. A very encouraging study for patients with stage 2/3 rectal cancer. More info here.
Leaders from across the NHS, government, industry and academia have called for a fundamental shift in how artificial intelligence is adopted across the health service, arguing that the NHS must move beyond isolated pilots and create clearer, faster routes to…
Health Innovation Kent Surrey Sussex (KSS) and Doctors Training have co-designed and co-delivered Generative AI (GenAI) training for NHS clinical staff, ensuring ethical, scalable, and high-quality workforce education.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us